Australia’s trusted independent immunisation experts


Pillsbury AJ, Fathima P, Quinn HE, Cashman P, Blyth CC, Leeb A, Macartney K . Comparative post-market safety profile of adjuvanted and high-dose influenza vaccines in the elderly. JAMA Open. 2020;3(5):e204079 . [Full text]

Deng L, Mab A, Wood N, Ardern-Holmes S. Vaccination management in an asymptomatic child with a novel SCN1A variant and family history of status epilepticus following vaccination: a case report on a potential new direction in personalised medicine. Seizure: European Journal of Epilepsy. 2020;78:49-52 . [Full text]

Leong NR, Wooda JG, Liu B, McIntyre PB, Newall AT . High healthcare resource utilisation due to pertussis in Australian adults aged 65 years and over. Vaccine. 2020;38:3553–3559 . [Full text]

Frank O, Bernardo C, Gonzalez-Chica DA, Macartney K, Menzies R, Stocks N . Pneumococcal vaccination uptake among patients aged 65 years or over in Australian general practice. Human Vaccines & Immunotherapeutics. 2020;16:965-971 . [Full text]

Netfa F, Tashani M, Booy R, King C, Rashid H, Skinner SR. Knowledge, Attitudes and perceptions of immigrant parents towards human papillomavirus (HPV) vaccination: a systematic review . Tropical Medicine and Infectious Disease. 2020;5:58 . [Full text]

Kaufman J, Attwell K, Tuckerman J, O'Sullivana J, Omar SB, Leask J, Regan A, Marshal H, Leea KJ, Snelling T, Perrett K, Wiley K, Giles ML, Danchin M. Feasibility and acceptability of the multi-component P3-MumBubVax antenatal intervention to promote maternal and childhood vaccination: a pilot study. Vaccine. 2020;38:4024-4031 . [Full text]

Wnukowski-Mtonga P, Jayasinghe S, Chiu C, Macartney K, Brotherton J, Donovan B, Hall M, Smith D, Peterson K, Campbell-Lloyd S, Selvey C, Gilles M, Kaldor J, Marshall H. Scientific evidence supporting recommendations on the use of the 9-valent HPV vaccine in a 2-dose vaccine schedule in Australia by the Australian Technical Advisory Group on Immunisation (ATAGI) . Communicable Diseases Intelligence. 15 April 2020. 2020;44 . [Full text]

Beard F, Hendry A, Macartney K . Influenza vaccination uptake in our most vulnerable groups: how well are we protecting them in 2019? . Communicable Diseases Intelligence. 15 April 2020. 2020;44 . [Full text]

Dey A, Wang H, Quinn H, Pillsbury A, Glover C, Hickie M, Wood N, Beard F, Macartney K. Surveillance of adverse events following immunisation in Australia annual report, 2018. Communicable Diseases Intelligence. 2020;44 . [Full text]

Patel C, Chiu C, Beard F, Crawford N, Macartney K . One disease, two vaccines: challenges in prevention of meningococcal disease. Medical Journal of Australia. 13 April 2020. doi: 10.5694/mja2.50567. [Abstract [Epub]]